文献速递细菌感染、耐药与抗菌药物医院感染防控

意大利医院获得性肺炎金黄色葡萄球菌全国调查:头孢吡普等药物活性及MRSA分子流行病学

Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

该研究分析了2016年意大利13个实验室收集的333株医院获得性肺炎(HAP)分离株,发现金黄色葡萄球菌占18.6%,其中MRSA占40.3%。头孢吡普对MSSA和MRSA的敏感性分别为100%和95.5%,MRSA以CC22、CC5和CC8为主,3株头孢吡普耐药MRSA均为ST228-MRSA-I(MIC 4 mg/L)。

要点

  • 意大利HAP中金黄色葡萄球菌占比18.6%,MRSA占40.3%。
  • 头孢吡普对MSSA和MRSA敏感性分别为100%和95.5%。
  • MRSA主要克隆为CC22(47.0%)、CC5(25.8%)和CC8(15.2%)。

核心结论

  • 金黄色葡萄球菌是意大利HAP的重要病原,头孢吡普对包括MRSA在内的分离株具有良好的体外活性。
  • 与既往研究相比,观察到ST228被ST22替代的趋势。

研究设计与样本

  • 2016年1月至5月从意大利13个实验室连续收集非重复HAP分离株,共333株。
  • 采用肉汤微量稀释法进行药敏试验,结果按EUCAST折点判读;所有MRSA分离株进行全基因组测序。

主要发现

  • 金黄色葡萄球菌是HAP中第三常见病原,占18.6%;MRSA占40.3%。
  • 头孢吡普对MSSA和MRSA的敏感性分别为100%和95.5%。
  • MSSA对红霉素和左氧氟沙星的敏感性分别为78.4%和94.6%;MRSA对红霉素和左氧氟沙星的敏感性分别为36.4%和12.1%。
  • MRSA主要属于CC22(47.0%)、CC5(25.8%)和CC8(15.2%),少数为ST1、ST6、ST7、ST30、ST152和ST398。
  • 3株头孢吡普耐药MRSA的MIC为4 mg/L,均属于CC5的ST228-MRSA-I。

关键数值与推荐

  • 药敏判读采用EUCAST折点;头孢吡普对MSSA敏感性100%,对MRSA敏感性95.5%。
  • MRSA对红霉素敏感性36.4%,对左氧氟沙星敏感性12.1%。

临床怎么用

  • 在意大利HAP经验性治疗中,头孢吡普对金黄色葡萄球菌(包括MRSA)覆盖良好。
  • 需关注MRSA克隆变迁,ST228被ST22替代可能影响耐药谱。

局限性

  • 研究仅纳入意大利13个实验室的分离株,代表性有限。
  • 头孢吡普耐药株仅3株,相关结论需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the prevalence of Staphylococcus aureus from hospital-acquired pneumonia (HAP) in Italy and the susceptibility to ceftobiprole and comparators of MSSA and MRSA isolates. A secondary objective was to characterize the clonality and acquired resistance and virulence genes of MRSA. METHODS: Consecutive non-replicate isolates from HAP were collected from 13 laboratories distributed across Italy, from January to May 2016. Antimicrobial susceptibility testing was performed by broth microdilution, and results were interpreted according to the EUCAST breakpoints. All MRSA isolates were subjected to WGS using an Illumina platform. Clonality and resistance and virulence gene content were investigated with bioinformatics tools. RESULTS: Among 333 isolates from HAP, S. aureus was the third most common pathogen (18.6%). The proportion of MRSA was 40.3%. Susceptibility to ceftobiprole was 100% for MSSA and 95.5% for MRSA. Lower susceptibility rates of 78.4% and 94.6% in MSSA and 36.4% and 12.1% in MRSA isolates were observed for erythromycin and levofloxacin, respectively. The MRSA from HAP mostly belonged to clonal complex (CC) 22 (47.0%), CC5 (25.8%) and CC8 (15.2%), with a minority of other lineages (ST1, ST6, ST7, ST30, ST152 and ST398). Acquired resistance and virulence genes in most cases exhibited a clonal distribution. The three ceftobiprole-resistant isolates exhibited an MIC of 4 mg/L and belonged to ST228-MRSA-I of CC5. CONCLUSIONS: S. aureus is an important cause of HAP in Italy. Ceftobiprole exhibited good in vitro activity against S. aureus isolated from HAP, including MRSA. A trend to replacement of ST228 with ST22 was noticed compared with previous studies.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Antonelli A, Giani T, Coppi M, et al. Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates. J Antimicrob Chemother. 2019. PMID: 31652323. doi:10.1093/jac/dkz371

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。